Health Trials

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Clinical Study Evaluating the Diagnostic Performance and Safety of PET for the Deposition of Aβ Plaques in the Brain of Participants With Normal Cognitive Function, MCI and AD Using [18F]Fluorbetazine Injection

A multicenter phase III clinical study evaluating the diagnostic performance and safety of PET for the deposition of Aβ plaques in the brain of participants with normal cognitive function, MCI and AD using \[18F\]Fluorbetazine injection.

Participants needed: 400
Trial details
Phase: Phase 3Age: 40+Biological sex: AllType: InterventionalSponsor: HTA Co., Ltd.Updated: Aug 14, 2026Locations: 1
Eligibility criteria

Known allergy to [18F]Fluorbetazine injection or its excipients. [+17]

Read more
Status: Recruiting

A Phase III Clinical Study to Compare the Safety and Efficacy of 177Lu-DOTATATE Injection and Long-acting Oxytrexine in Adult Patients With NETs

The study is to evaluate the sstr antagonists, 68Ga-DOTATATE and 177Lu-DOTATATE,as a pair of diagnostic/therapeuticradiopharmaceuticals(theranostics)in patients with NETS

Participants needed: 184
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: HTA Co., Ltd.Updated: Jul 10, 2025Locations: 1
Eligibility criteria

Ability to understand and the willingness to sign a written informed consent doc... [+6]

Human immunodeficiency virus (HIV) antibody positive; [+12]

Read more
Status: Recruiting

Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer

In this study, 18F-Florastamin PET/CT will be performed in patients with suspected recurrence of prostate cancer, to assess the diagnostic performance and safety of 18F-Florastamin PET/CT imaging.

Participants needed: 131
Trial details
Phase: Phase 3Age: 18+Biological sex: MaleType: InterventionalSponsor: HTA Co., Ltd.Updated: Dec 31, 2024Locations: 1
Eligibility criteria

Subjects fully understood the content, process, and potential risks of the study... [+8]

Subjects who have participated in other interventional clinical trials before si... [+4]

Read more